The real goal is getting value to the bedside
Start from what a health system actually wants: an AI scribe that gives clinicians their evenings back, triage that clears a backlog, coding that stops leaking revenue. The value is not in doubt. What stalls it is the fear of what happens when that AI touches protected health information or a care decision, and that fear is usually why a promising pilot sits in a committee for a year. Governance is what breaks the deadlock. Treated as part of delivery rather than a gate bolted on at the end, it is the thing that lets you say yes to a use case quickly and still defend it later. The organizations moving fastest on healthcare AI are not the ones being reckless; they are the ones who made governance a lane, not a wall.
Picture the workflow you're actually trying to ship
Picture a hospital rolling out an AI assistant that drafts discharge summaries. Clinicians love it in week one. By week three, someone pastes a full patient record into a public model to save time, another team wires it into a system nobody reviewed, and the compliance lead finds out from a vendor invoice. Nothing here was malicious. The tool was useful and the guardrails were a memo. That gap, between a genuinely valuable workflow and any real control over how it is used, is the problem governance for healthcare has to solve, and it is solvable without killing the thing people liked.
Settle the data question once
The first decision that unlocks speed is which data may reach which model, and where that gets checked before a call leaves for an external service. Prompts written by busy staff carry names, identifiers, and clinical detail, most of which should never leave the building. Teams that ship fast do not solve this with a policy asking people to be careful; they build the check into the approved way of working and keep a record of what went out and came back. That record is what lets a health system use a hosted model at all, because it turns an open question into something it can show was handled correctly, on demand, to whoever asks.
Give people an approved path, not a locked door
Be honest about the starting point: staff are probably already using AI tools nobody approved, with good intentions and rough data hygiene. Banning them fails because the demand is real, and driving that usage underground is worse than seeing it. The trade clinicians will actually take is a sanctioned path that does the same job with the data handling and record-keeping already in place. Decide up front which models are cleared for which work, so a tool fine for drafting internal notes is nowhere near a patient record, and make those decisions in the open so they hold as new tools and teams appear. Discovery comes first, because you can only govern the usage you can see.
Keep evidence you can hand to an auditor
Internal compliance, external auditors, regulators under HIPAA and the EU AI Act: they all ask the same question, which is show me what happened. A health system that captures a clear trail of its AI use as it happens, which model handled a request, what kind of data was involved, who authorized it, answers that in a morning instead of a fortnight. Evidence gathered while the work runs is worth more than logs reconstructed after a regulator calls. It is also what separates a team that claims to govern its AI from one that can prove it, and in a regulated setting that difference is the whole ballgame.
A stage-by-stage path, and where a partner helps
A workable sequence: find where AI is already running, bring that usage onto an approved footing, settle data handling and access for the highest-risk flows first, then add the reporting compliance needs. Prove the controls on one narrow, high-value workflow before widening out, so you earn trust with a result rather than a plan. Most healthcare teams do not have spare capacity to design all of this from scratch while also running a hospital, which is where an outside partner earns its keep: a short assessment that maps where you are, names the use cases worth doing, and lays out a governed path to production tends to move a stuck program further in a fortnight than another round of internal debate. The point of all of it is not caution for its own sake. It is to give clinical innovation a safe lane, so the AI that helps patients can actually reach them.
Frequently asked questions
Can a hospital use hosted LLMs safely?
Yes, provided sensitive data is governed before it reaches the model and every use is recorded. The safe version is an approved path where the data check and the record-keeping are built in, not a policy asking staff to be careful, so a hosted model helps without exposing protected health information.
Does governance slow clinical AI down?
Done as a bolt-on at the end, yes. Done as part of how the workflow ships, it usually speeds things up, because the hard questions are settled once instead of re-argued at every launch, and approved use cases stop waiting on a committee.
Where should a healthcare AI program start?
With a look at where AI is already being used and which use cases are worth doing, then a governed path to production for the highest-value one. A short external assessment is often the fastest way to turn a stalled program into a shipped result.